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Phorbol  myristate  acetate  (PMA) 1 is  a  cocareinogen  that  potentiates  tumor  for- 
mation by suboptimal doses of initiators and induces an intense inflammatory reaction 
in mammalian  skin  (1,  2).  It has a  number of pleiotropic effects on cells in culture, 
including their differentiation and enhanced replication and secretion (for review see 
[3, 4]). When added to explanted macrophages, it produces dramatic changes in cell 
shape,  spreading,  endoeytosis,  and  the  release  of neutral  proteinases  and  oxygen 
metabolites  (5-8).  These  changes  resemble  some  of the  metabolic  and  structural 
correlates of macrophage activation, a  process that has recently been shown to result 
in enhanced phagosome-lysosome (P-L) fusion (9). 
Using a  previously described  fluorescence assay  (10),  we have now carried  out  a 
detailed study of the effects of PMA on macrophage membrane fusion. In this article 
we demonstrate that PMA in submicrogram doses markedly stimulates both the rate 
and  extent  of  fusion  of  phagosomes  with  preexisting  secondary  lysosomes.  The 
association of PMA with macrophages, the longevity of its affect on fusion, and the 
fate of macrophage-associated PMA have also been examined. 
Materials  and Methods 
Cells and  Culture  Conditions.  Resident  peritoneal  macrophages were obtained  from female 
Nelson-Collins strain mice and cultured as previously described (10). J774 cells were maintained 
in spinner culture and were kindly provided by Dr. J. Unkeless, The Rockefeller University, 
New York. These cells were plated at a  density of 1.3 ×  10  s per 35-mm culture dish for 2 h 
before being used in PMA studies. Primary rat embryo fibroblasts were from Microbiological 
Associates,  Walkersville, Md., and were generously provided by Dr. R. Steinman, The Rocke- 
feller  University,  as  aliquots  frozen  in  medium  with  20%  fetal  calf serum  (FCS)  and  5% 
dimethyl  sulfoxide  (DMSO).  Cells were thawed,  washed,  plated  in  35-mm dishes,  cultured 
overnight, and used the next day at densities just below confluence. 
Assay  of P-L  Fusion.  P-L fusion  in  mouse  macrophages was  assayed by monitoring  the 
transfer of a fluorescent vital dye from lysosomes to phagocytic vacuoles as previously described 
(10). Briefly, cover slip cultures were labeled for 20 min with 5/~g acridine orange/ml, washed, 
and a dilute suspension of serum-opsonized, heat-killed yeast particles was centrifuged onto the 
cell monolayer at 4°C. Unbound yeast was washed away, and the cultures were rapidly warmed 
to 37°C to synchronize particle ingestion. Viable cells were examined by fluorescence micros- 
copy at various times after an initial  10-min ingestion period. The presence of orange-stained 
intracellular yeast was considered positive for P-L fusion. 
* Supported by grant AI-07012 from the National Institutes of Health. 
1 Abbreviations used in this paper: DMSO, dimethyl sulfoxide; FCS, fetal calf serum; [nH]PMA, [20-3H]- 
phorbol myristate acetate;  MEM, modified Eagle's medium; P, phorbol, PA, phorbol-13-acetate; PBS, 
phosphate-buffered saline; P-L, phagosome-lysosome;  PM, phorbol-12-myristate; PMA, phorbol myristate 
acetate; TLC, thin-layer chromatography. 
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Association of [20-3H]Phorbol-12-Myristate-13-Acetate ([aH]PMA) with Macrophages.  Uptake 
and efflux studies were performed with [20-zH]PMA at a specific activity of 4 ×  10s-5  X  l0  s 
cpm/#g. PMA in DMSO Was added to 15% FCS-modified Eagle's medium (MEM) at a final 
concentration of  0.1 #g/ml PMA and a maximum of 0.5% DMSO. Cover slip cultures in Costar 
tissue-culture trays (Costar, Data Packaging, Cambridge, Mass.)  were exposed to 0.5-1.0 ml of 
PMA-containing medium for the required times.  This medium was then removed, cover slips 
washed  once  in  phosphate-buffered  saline  (PBS)  containing  1%  FCS,  and  then  washed 
sequentially in three beakers of ice-cold PBS. Cover slips were added to scintillation vials, the 
cells were solubilized in 200/xl  2% sodium dodeeyl sulfate,  and counted in 3 ml Hydrofluor 
(National Diagnostics, Somerville, N. J.). Under these conditions, the cover slips alone or the 
cell  cultures at 2°C (time zero) bound from  100 to 400 cpm. This protocol was also used to 
follow the efflux of [3H]PMA from prelabeled macrophages. 
Metabolism of[sH]PMA.  1 ml of [sH]PMA in 15% FCS-MEM was added per 35-ram dish 
of cells, at a concentration of 0.1/~g PMA/ml and specific activity of 2 X  10  cpm//~g. After 
being pulsed with PMA, cells were washed three times with 5% FCS-PBS, scraped into normal 
saline,  and  extracted  with  three  1-vol washes ethyl acetate  (11).  Medium  containing label 
released from cells was similarly extracted. For most samples, 30 #g each of unlabeled PMA, 
phorbol-12 myristate (PM), phorbol-13-acetate (PA), and phorbol (P) were added as standards 
just  before extraction.  Greater than  90%  of the original radioactivity was recovered  in  the 
pooled ethyl acetate washes.  Extracts were concentrated under N2 and chromatographed on 
silica  gel 60 plates using two developments in dichloromethane:acetone (3:1 vol:vol). Internal 
standards were detected by I2 staining and lanes containing standards alone were visualized by 
I2 or vanillin:H2SO4 (12). Both sets of standards showed the same migration. [3H]PMA gave a 
single radioactive peak that  corresponded to unlabeled  PMA. Similar results were obtained 
using  water-saturated  diethyl  ether  or  chloroform:acetone  (3:1)  as  solvents,  although  the 
CH2Cl~:acetone system gave better separation of PA and PM. 
Plates were sectioned into 1-cm strips,  scraped, and fractions counted in 0.5 ml H20 plus 3 
ml Hydrofluor. 
Reagents.  [nH]PMA was obtained  from New England  Nuclear,  Boston, Mass.  PMA was 
from Consolidated Midland Corp., Brewster, N. Y. P, PM, and PA were from Dr. P. Borchert 
at Chemical Carcinogenesis Co., Eden Prairie,  Minn.  All phorbol derivatives were stored as 
stock solutions at -70 in the dark. Precoated silica gel 60 plates (0.25 mm) were from E. Merck, 
Darmstadt, Federal Republic of  Germany, and were prerun in ethyl ether before use. Superoxide 
dismutase  (2,900  U/mg, from bovine blood), eatalase  (32,000  U/rag,  from beef liver),  indo- 
methacin, hydrocortisone-21-phosphate (disodium salt), and puromycin dihydroehloride were 
from Sigma Chemical Co., St.  Louis, Mo. Cycloheximide was from Boehringer und  Soehn, 
Mannheim, Federal Republic of Germany. 
Results 
The Stimulation of  P-L Fusion by PMA.  The addition of PMA to macrophage cultures 
lead to a stimulation of P-L fusion within the first  15 min after particle ingestion (Fig. 
1). This occurred with doses from 0.1  to  1.0/~g PMA/ml  (1.6 ×  10-7-1.6 ×  10 -6 M) 
and lead to an increase in both the rate and extent  of fusion comparable with that 
observed previously in activated populations  (9)  or long-term cultures  (10).  Neither 
the DMSO carrier alone nor 0.001/~g PMA/ml  had a  demonstrable effect on fusion. 
The addition  of the nonesterified  alcohol P  or the monoesters PM or PA at concen- 
trations of 1.6 X  10-~-1.6 X  10 -6 M  were also without effect on fusion. 
The  dose-response  determinations  reported  above  were  all  performed  in  cells 
exposed  to PMA  for a  2-h  preincubation  period.  This  was required  because of the 
pronounced lag between the addition of PMA and the expression of enhanced fusion 
(Fig.  2). These results contrast with the almost instantaneous  effects of PMA on the 
spreading of maerophages  (5)  and the release of H~O2 (8). 
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FIG.  I.  The effect of pretreatment with PMA on P-L fusion. Rate of P-L fusion in cells cultured 
for 2 d and pulsed for 2 h with either PMA, P, or 0.33% DMSO (highest concentration  used for 
PMA addition). (O--O)  1 ~g PMA/ml; (0--0) 0.1 #g PMA/ml; (O.--.O) 0.001 ~g PMA/ml; 
(0--0) 1 #g P/ml; (ZX)  0.33% DMSO. 
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FIG. 2.  Time of PMA pretreatment necessary for enhancement  of P-L fusion. 2-d cultures were 
pulsed with 1 #g/ml PMA for the indicated times before particle addition and fusion assay. One set 
of cover slips (ZX) was given PMA after particle addition but just before being warmed to 37°C and 
was maintained in PMA-containing medium. 
2 exhibit enhanced fusion throughout the period of assay. Because some of the other 
effects of PMA on macrophage physiology are short-lived, it was of interest to examine 
wash-out  experiments carried out  for longer time periods after pretreatment.  Fig. 3 
shows  that  the  removal  of PMA  after  2  h  of pretreatment  results  in  a  sustained 
enhancement  of fusion  for  ~20  h  of additional  culture  in  PMA-free  medium.  It 
appears therefore that after a  relatively long induction period the presence of PMA 
is not required to maintain a  maximum fusion response. 
The Association of [3H]PMA  with Macrophages.  The  kinetics  of PMA-stimulated 
fusion raised many questions concerning the association and fate of PMA  in macro- 
phages. For this reason, we obtained the tritiated compound and first examined the 
rates of its uptake and release by cultured macrophages. 
The  association of [aH]PMA  with  macrophage  monolayers showed  a  rapid  and 
linear  increase  until  2-4  h  (Fig.  4A).  No  significant  increase  above  this  plateau 
occurred with continued incubation up to 24 h. Thus the time-course of the uptake 
of PMA paralleled the time course of its effect on fusion. 104  PHAGOSOME-LYSOSOME FUSION IN MOUSE  MACROPHAGES 
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Fro.  3.  Maintenance of PMA effect after treatment. Cultures were pulsed for 2 h with 0.1 ~g/ml 
of PMA either immediately (O)  or 20 hr before assay  (©), washed, and  returned  to  PMA-free 
medium. Controls received 0.03% DMSO (A). All three cell populations have been in culture a 
total of 48 h. 
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Ftc;.  4.  Uptake and efflux of [aH]PMA in macrophage cultures.  (A) Association of [aH]PMA with 
macrophages.  2-d cultures were exposed  to medium containing 0.1 #g/ml PMA at 370C  for the 
indicated  times.  Points are the average counts  per minute  for triplicate cover slips  at  5  X  105 
peritoneal cells per cover slip. Maximum incorporation was  1.7% of the added label. (B) Efflux of 
[sH]PMA  from macrophages.  1-d cells  were exposed  to 0.1  #g/ml  PMA for 3  h,  washed,  and 
returned to culture (time zero) in 15% FCS-MEM. At various times thereafter, triplicate cover slip 
cultures were assayed  for cell-associated  and released  label. Incorporation at time zero was 2.2% of 
the added label. 
After a  pulse  of labeled  PMA,  cell-associated  label  was  rapidly  released  into  the 
medium  and  returned  to background  levels within  1 h  (Fig. 4 B), whereas  the effect 
on  fusion  continued  for _>20  h  (Fig.  3).  Thus  the  continued  physical  association  of 
PMA  with macrophages  is not necessary to maintain  the enhanced  fusion rate. 
Prior  uptake  and  release  of PMA  by  macrophages  did  not  alter  the  subsequent 
uptake  of additional  PMA.  Label  was  released  somewhat  more  slowly  in  medium 
without  serum.  Lower serum  concentrations  were  used  in  the  following chromatog- 
raphy  experiments,  both  to  facilitate  extraction  and  to  enable  the  comparison  of 
released  and  cell-associated  label.  Results  were  qualitatively  the  same  for  1-15% 
serum concentrations. 
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medium were extracted in ethyl acetate and analyzed by thin-layer chromatography 
(TLC) (Materials and Methods). Label associated with cells at the start of the 90-min 
incubation comigrated with the PMA standard (data not shown). Label that was still 
cell-associated at the time of extraction chromatographed as shown in Fig. 5 B. The 
major peak of the material comigrated with the PMA standard, whereas some label 
ran as a  more polar material between unesterified P and PM. 
Label  that  was  released  from  macrophages  was  almost  exclusively  the  polar 
metabolite and little if any unmodified PMA remained (Fig.  5 A). In contrast, PMA 
incubated in medium without cells comigrated with the PMA standard after extrac- 
tion and chromatography. Thus macrophages appear to metabolize and de-esterify 
PMA  to  a  more  polar  product,  with  an  Rf value  not  identical  to  either  of the 
monoesters, and close but not identical to that of the parent alcohol. Because many 
oxidation products of PMA are possible  (13),  the  metabolite could be  an  oxidized 
form of P or the monoester. 
When the released label was extracted, concentrated, resuspended in fresh medium, 
and added  to macrophages, little  or no rebinding of the metabolite occurred. This 
implies that PMA remains cell-associated only when present as the intact molecule. 
Metabolism of PMA by Other Cell Types.  We wished to compare the metabolism of 
PMA  by  the  highly  endocytic  mouse  macrophage  with  that  of other  cell  types. 
Accordingly, release  and  chromatography studies  were  performed for J774  cells,  a 
macrophage-like murine  cell  line  originally derived from a  reticulum  cell  sarcoma 
(14),  and for primary rat embryo fibroblasts. As shown in Fig. 6A and B, J774 cells 
rapidly released  labeled  PMA after a  pulse,  and  most of the  label  in  the  medium 
again migrated between P and PM. Label that was still  cell-associated at the time of 
extraction  mainly  appeared  to  be  unmodified  PMA.  Thus,  the  rapid  release  of 
metabolized PMA by J774 cells  is similar to that of freshly explanted macrophages. 
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FIG.  5.  TLC  of released (A)  and cell-associated (B)  label from  primary macrophage cultures 
treated with 0.1 #g/ml [aH]PMA.  Two 35-mm dishes of 24 h macrophages  were treated with PMA 
for 4 h, washed, and recuhured in 2% FCS-MEM without PMA for 90 min. Cells and medium were 
then extracted, chromatograpbed, and analyzed as described in  Materials and  Methods. Top: 
positions of standards (P, PM, PA, PMA) included on the same TLC. Solvent front was at 19 cm. 
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FIo.  6.  TLC of released (A) and cell-associated (B) label from J774 cultures and released (C) and 
cell-associated (D) label from rat embryo fibroblast cultures treated with 0.1 #g/ml [oH]PMA. Two 
35-ram dishes of each cell type were treated with PMA for 2 h, washed, and recuhured in  1% FCS- 
MEM without  PMA for 90 rain. Cells and medium were then extracted and chromatographed. 
Top: positions of standards (P, PM, PA, PMA) included on the same TLC. Solvent front was at  19 
cm for both developments in CH,aCl2:acetone. MARGARET C.  KIELIAN AND ZANVIL A. COHN 
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FIG.  7.  (A) The effect of protein synthesis inhibitors on the enhancement of P-L fusion by PMA. 
1-d cultures were incubated for 2 h in normal medium or medium containing 10 lag/ml puromycin 
or 5 #g/ml cycloheximide. PMA (0.2 #g/ml) was then added for 5 h to all except untreated cultures. 
Fusion was assayed as usual except that  medium  contained  protein  synthesis inhibitors where 
indicated.  (B)  The effect of protein  synthesis inhibitors on  P-L fusion in  4-d cells. Cells were 
preincubated  for 5 h in medium alone or medium containing  10 #g/ml puromycin or 5 Ixg/ml 
cycloheximide. These concentrations were included during the fusion assay where indicated. 
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The  results  of a  similar  experiment  with  rat  embryo  fibroblasts  were  somewhat 
different from those with macrophages. The release of PMA was slower than for J774, 
and  37%  remained  cell-associated  at  90  min.  Cell-associated  label  (Fig.  6D)again 
was  almost  exclusively unmodified  PMA.  Released  label  (Fig.  6C)  showed  greater 
heterogeneity  with  three  radioactive  peaks,  one  of which  comigrated  with  PMA 
standard, one of which ran as the usual metabolite seen with the other cell types, and 
a  third broad intermediate  peak that migrated as PA. 
Fusion and the  Other Metabolic Consequences of PMA.  PMA is  known  to trigger  the 
release of oxygen intermediates by macrophages (7, 8) and to stimulate the production 
of prostaglandins  (15,  16). The enhancement of P-L fusion by PMA was not blocked 
by concurrent  treatment  throughout  the assay with superoxide  dismutase  (1350 U/ 
ml) or catalase (15,000 U/ml). These conditions inhibit microbicidal and tumoricidal 
activities in macrophages by hydrolyzing OF or H202. Preincubation of macrophages 
with  10  -5  indomethacin  for  I  h  and  its  presence  during  PMA  stimulation block 
prostaglandin production  (17), but were without effect on the increase in fusion. 
The increased pinocytic rate seen in PMA-treated macrophages (5) can be'reversed 
by  10 -5  M  colchicine,  whereas  enhanced  fusion  was  unaffected  by  treatment  of 
macrophages  with  colchicine  at  10 -5  M.  Finally,  the  induction  of  plasminogen 
activator  secretion  by PMA  is  inhibited  by glucocorticoids  (6),  whereas  the  fusion 
effect was not reduced by  10  -~ M  hydrocortisone, a  concentration that shows potent 
inhibition  of the secretion of this enzyme (18). These studies imply that the effect of 
PMA on fusion can be dissociated from several of its other effects on macrophages. 
PMA-stimulated  P-L Fusion Requires Protein Synthesis.  The pronounced lag phase of 
PMA stimulation,  its rapid deesterification  and release from the macrophage and its 
prolonged  influence  when  PMA was removed  from the  medium suggested  that  the 
molecule had induced the formation of a  relatively stable product. Becauseblocking 
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of P-L fusion, we were interested to know if the enhancement was  mediated by a 
protein  product.  For this  purpose,  we employed the  inhibitors cycloheximide and 
puromycin in concentrations that  inhibit  [aH]leucine incorporation by 90% (6) and 
the reexpression of surface receptors (19). The results are presented in Fig. 7.  1 d after 
explanting macrophages, the fusion rate is normally low (Fig. 7 A) and PMA showed 
a  dramatic stimulatory effect. Pretreating the  macrophages with  inhibitors almost 
completely  ablated  this  effect.  Similar  results  were  obtained  2  d  after  explant. 
However, 4 d after in vitro incubation, the fusion rate of untreated cells had already 
reached maximum levels (10)  and the addition of PMA had little influence. Under 
these conditions, neither puromycin nor cycloheximide influenced the rate of fusion 
over a 5-h exposure (Fig. 7 B). 
Discussion 
PMA, a  fatty acid diester of a  tetracyclic diterpene alcohol, is the most active of 
several compounds purified from croton oil  (1).  It is an inflammatory agent and a 
very potent  tumor promoter, although continued applications of promoter are  re- 
quired to produce tumors in the mouse skin carcinogenesis assay (2). Since this work, 
many activities of PMA on cultured animal cells have been described (for review see 
[3, 4]). These fall under two general headings: First, that PMA causes changes that 
mimic or accentuate the transformed phenotype, such as loss of  cell-surface fibronectin 
or induction of plasminogen activator. Second, PMA appears to modify cell differ- 
entiation, for example, by inhibiting myogenesis. 
In  macrophages, the  following sequence of events occurs after PMA treatment: 
within the first 10-20 min after the addition of PMA to resident macrophage cultures, 
the  cells  spread  on  the  substrate  (5),  and  within  the  first  30  min,  a  burst  of 
prostaglandin and thromboxane release is observed (15,  16). Another rapid effect of 
PMA is the dramatically increased release of products of the reduction of molecular 
oxygen such as  H202 (8)  and O~"  (7).  This release is much greater when activated 
macrophages are treated, and unelicited cells show only a  small increase in release. 
Within  1 h of PMA treatment, stimulation of fluid-phase pinocytosis and topological 
rearrangement  of lysosomes into  a  radial  pattern  along  microtubules occurs  (20). 
Again, these two effects are much more pronounced in elicited rather than resident 
cells. 
In contrast to these rapid effects, the induction of plasminogen activator in resident 
macrophages was much slower, had a lag period of several hours, and continued for 
at least  24 h  in culture after induction  (6).  In these aspects, the effect of PMA on 
fusion  resembles  the  induction  of plasminogen  activator,  and  is  also  expressed  in 
unelicited cells. The requirement for the continued presence of PMA in these other 
macrophage responses has not been well-characterized. There is some evidence that 
the effect of PMA on fusion is dissociable from other effects because it is not blocked 
by catalase, superoxide dismutase, indomethacin, colchicine, or hydrocortisone. 
Uptake and Metabolism of [aH]PMA.  PMA  is  a  very lipophilic  molecule and  is 
known  to interact with  phosphatidyl choline monolayers, changing  the monolayer 
surface pressure  by physical  intercalation,  although  having  no apparent  effect on 
model membrane permeability or fluidity (21).  Using  [3H]PMA, the association of 
PMA with macrophages was examined to see ifa physical intercalation might explain 
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The results reported here indicate that mouse macrophages rapidly take up [aH]- 
PMA from the culture medium, as has been described for several other cell types in 
culture (11, 22). Linear uptake levels off after ~3 h, at which time -2% of the added 
label  is  cell-associated, or ~6.4  X  10  -12 mol  PMA/1  ×  106 peritoneal cells plated. 
When cells are returned  to PMA-free medium,  this label  is  rapidly released. Cell- 
associated label appears to be unmodified PMA, whereas the released form migrates 
as a more polar compound in TLC. All of the label partitions into the organic phase 
during  extraction,  implying that  the  aH  is  still  on  the  phorbol  skeleton,  and  the 
compound migrates between P  and  PM.  As others have reported (23, 24), we also 
found that  PA migrated  faster than  PM,  in  spite of the shorter length  of its  acyl 
chain. 
The  release  of metabolized  PMA  suggests  that  the  plateau  of uptake  does  not 
represent a saturation of specific binding sites for PMA. Rather, an equilibrium seems 
to be established between the uptake of native PMA and the release of the metabolized 
form. The macrophage cell line J774 showed similar rapid kinetics of PMA uptake 
and metabolism, producing a  form that migrated in the same position as that from 
primary macrophages. Primary rat embryo fibroblasts had somewhat slower kinetics 
of release, and much of the label released was either unmodified PMA or ran at the 
same position as PA. Thus, results with rat fibroblasts are more similar to results in 
the literature in which either no metabolism of PMA was seen (11,  22, 23, 25) or in 
which PA was the only metabolite seen (23, 24). Human cells have been reported not 
to metabolize PMA (23, 26), and it would be interesting to know if this were true for 
human macrophages as well. 
The effect of PMA on P-L fusion is maintained for hours after the release of PMA 
from treated cells, and thus this effect is not dependent on the physical association of 
PMA with membranes (21) or continued binding to a specific receptor (11, 27). The 
time-course of the PMA effect and  its inhibition by puromycin and cycloheximide 
suggest that PMA is inducing the synthesis of a protein or proteins that mediate the 
effect. 
Comparison with Other Modulators of P-L Fusion.  P-L fusion is inhibited by several 
intracellular parasites (28), by lysosomal uptake of polyanions (29), and by decreased 
temperature (10). Fusion is dramatically increased by time in culture (10), by in vivo 
macrophage activation  (9), and by PMA pretreatment, as reported here, while it is 
insensitive to a great number of other variables (10). Thus PM,  A pretreatment is one 
of a very limited number of experimental conditions able to modulate fusion. PMA 
may be inducing protein(s) in early cultures that are already present at higher levels 
in activated and 4-d cultures. This product could be an integral membrane protein of 
lysosomal or plasma membrane that directly influences fusion of its surrounding lipid 
domain. Another possibility is that a cytosolic or loosely associated membrane protein 
could  be  acting  between  the  phagosome  and  lysosome membranes  to  affect their 
fusion. The lack of inhibition by puromycin and cycloheximide in 4-d cultures implies 
that  if such molecules are involved, their turnover rate is slow. Slow turnover of a 
protein mediator would also explain the stability of the increased fusion rate for 20 h 
after the removal of PMA. 
Summary 
The effect of the tumor promoter phorbol myristate acetate (PMA) on phagosome- 
lysosome  (P-L)  fusion  in  mouse macrophages  has  been  studied  using  a  previously 110  PHAGOSOME-LYSOSOME  FUSION IN MOUSE MACROPHAGES 
described  (10)  fluorescence  assay.  Treatment  with  0.1-1.0  /~g  PMA/ml  caused  a 
striking increase in the rate and extent of P-L fusion. Exposure of cells to phorbol, free 
myristate,  or  the  monoesters  of PMA  did  not  reproduce  this  effect.  Macrophages 
required from 2 to 3 h of pretreatment  to express maximal P-L fusion, and this was 
maintained for at least 20 h when cells were returned to PMA-free medium. 
Catalase, superoxide dismutase, indomethacin, and hydrocortisone, agents that are 
known  to  block  the  effect  of PMA on  H~O2, O~-, prostaglandins,  or  plasminogen 
activator, did not affect the stimulation of P-L fusion by PMA. The protein-synthesis 
inhibitors puromycin and cycloheximide did block the PMA effect under conditions 
in which the high fusion rate of 4-d cells was not affected. 
Labeled PMA was rapidly taken up by macrophages, with a plateau of uptake at 
~3  h.  When  cells  were  returned  to  PMA-free  medium,  cell-associated  label  was 
rapidly released,  returning to background levels within  1 h.  The released label  was 
found  to  be  a  metabolite  of PMA  by  thin-layer  chromatography.  This  product 
migrated  between  the  monoester  phorbol-12-myristate  and  free  phorbol.  Rapid 
metabolism of PMA was also observed by a  macrophage cell  line, J774,  and,  to a 
lesser  extent, by primary rat embryo fibroblasts. 
We thank Richard Huntley for technical assistance, Grace Silvestri for typing the manuscript, 
and Dr. William  Scott for advice on the chromatography. 
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